Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that ongoing medical therapy is crucial for preventing hair loss, and surgical options can restore hair, with future treatments for hair loss being promising.

Anifrolumab helped some lupus patients reduce steroid use, but safety concerns remain.

The document concludes that various dermatological treatments and drugs can cause skin reactions and side effects.

Activated PRP effectively increases hair density and reduces hair loss in alopecia.

The consensus document recommends a comprehensive treatment plan for Hidradenitis Suppurativa, including various medications, surgery, lifestyle changes, and the need for more research and resources.

Treating psoriasis on the scalp, nails, and skin folds is challenging, often requiring systemic treatments for severe cases, with some success in topical and biologic treatments.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Hair pulling disorder is treated with therapy and medication; hair loss from tension can be reversed if caught early.

New skin treatments in 1987-1988 showed effectiveness for various conditions, but some had side effects or risks.

Alopecia Areata is an autoimmune condition often starting before age 20, with varied treatment success and a need for personalized treatment plans.

Upadacitinib effectively treats skin conditions like eczema and psoriasis and is becoming more widely used and affordable.

Low level laser therapy works best for hair loss, followed by PRP, finasteride, and minoxidil.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

JAK inhibitors effectively regrow hair in alopecia areata but hair loss often returns after stopping treatment.

The document concludes that alopecia has various forms, each with specific treatments, but no definitive cure for certain types like CCCA has been proven.

The document concludes that managing PCOS involves treating symptoms, regulating periods, and reducing health risks, with specific medications for fertility and metabolic issues.

The document says that there are treatments for hair and nail diseases.

JAK inhibitors may help treat certain types of hair loss, but more research is needed.

Janus kinase inhibitors are promising for treating scarring alopecia, but more research is needed for safety and personalized treatments.

JAK inhibition may help manage autoimmune conditions in Down syndrome.

Ritlecitinib is effective and safe for treating severe alopecia areata in people aged 12 and older.

JAK inhibitors show promise for treating alopecia areata but have serious side effects.

New regenerative treatments show promise in improving hair growth for androgenetic alopecia.

Combining platelet-rich plasma and minoxidil can effectively regrow hair in severe alopecia areata cases.

Six genetic conditions are often linked to complete scalp hair loss in children.

Many treatments for hair loss show potential, but more testing is needed to confirm their effectiveness. Only minoxidil for women and minoxidil and finasteride for men are FDA approved.

Using platelet-rich plasma in hair restoration surgery significantly improves hair density after 6 months and is safe to use.

JAK inhibitors, like baricitinib, are effective and safe for treating alopecia areata.

Sorafenib can cause a temporary skin condition that goes away after stopping the drug.

Minoxidil foam effectively promotes hair growth and reduces hair loss in men.